Literature DB >> 2415186

Clonal analysis of basophil differentiation in bone marrow cultures from a Down's syndrome patient with megakaryoblastic leukemia.

T Suda, J Suda, Y Miura, Y Hayashi, M Eguchi, K Tadokoro, M Saito.   

Abstract

We present the in vitro differentiation of marrow cells from a patient with Down's syndrome accompanied by megakaryoblastic leukemia into basophils in the presence of phytohemagglutinin-stimulated leukocyte conditioned medium, using a liquid culture and methylcellulose culture system. Identification of basophils was established by metachromatic staining with toluidine blue, transmission electron microscopy, and the presence of histamine. However, these basophils did not release histamine in response to calcium ionophore or chemotactic peptide. Samples from suspension cultures that contained 90% basophils showed chromosomal markers characteristic of leukemic cells (48, XY, +11, +21, t(1;15)) in all examined mitoses. The cellular composition of leukemic colonies grown in methylcellulose culture from single cells was studied using the micromanipulation technique. High plating efficiency and extreme predominance of basophil colonies were observed. In a total 137 cultures, 79 revealed colony growth. Of 59 colonies that were analyzed by cytologic examination, 46 were pure basophil colonies. These basophil colonies showed disperse morphology, similar to that of a normal basophil colony. The clonality of the basophil colonies and skewing of lineage expression were documented from leukemic single-cell cultures. These data showed that leukemic cells have the capacity for differentiation into some lineages that are not expressed in vivo.

Entities:  

Mesh:

Year:  1985        PMID: 2415186

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome.

Authors:  A O Wilkie; C Kitchen; A Oakhill; R T Howell; P J Berry
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

2.  Ultrastructural investigation of DNA in megakaryoblastic leukemia by using osmium-ammine-B: comparison with several types of leukemia.

Authors:  Y Ohwada; M Eguchi
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

3.  Basophils in acute myeloid leukaemia.

Authors:  C F Hoyle; P D Sherrington; P Fischer; F G Hayhoe
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

4.  G-protein-coupled receptors in normal human erythroid progenitor cells.

Authors:  H Porzig; R Gutknecht; G Kostova; K Thalmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

5.  Crosstalk between thrombin and adenylyl cyclase-stimulating agonists in proliferating human erythroid progenitor cells.

Authors:  H Porzig; R Gutknecht; K Thalmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

6.  Leukaemia and transient leukaemia in Down syndrome.

Authors:  L Iselius; P Jacobs; N Morton
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

7.  Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system.

Authors:  E Kajii; F Umenishi; S Iwamoto; S Ikemoto
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

8.  GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.

Authors:  A Maroz; L Stachorski; S Emmrich; K Reinhardt; J Xu; Z Shao; S Käbler; T Dertmann; J Hitzler; I Roberts; P Vyas; G Juban; C Hennig; G Hansen; Z Li; S Orkin; D Reinhardt; J-H Klusmann
Journal:  Leukemia       Date:  2013-12-13       Impact factor: 11.528

9.  Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.

Authors:  H Ema; T Suda; S Sakamoto; T Tomonaga; J Tsunoda; K Muroi; N Komatsu; A Miwa; A Ohsaka; M Yoshida
Journal:  Jpn J Cancer Res       Date:  1989-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.